Lupus kidney drug trial pulled before it began
NCT ID NCT04883619
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 22 times
Summary
This study aimed to test whether nipocalimab, an experimental drug, could help people with active lupus nephritis (kidney inflammation caused by lupus). The trial was planned for adults with confirmed kidney disease and high protein in their urine. However, the study was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS NEPHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.